nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of possible atypical demyelinating event of the central nervous system following COVID-19
|
Zoghi, Anahita |
|
|
44 |
C |
p. |
artikel |
2 |
Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases
|
Comini-Frota, Elizabeth R. |
|
|
44 |
C |
p. |
artikel |
3 |
Age at onset correlate with disability in Latin American aquaporin-4-IgG-positive NMOSD patients
|
Carnero Contentti, Edgar |
|
|
44 |
C |
p. |
artikel |
4 |
A new paraplegin mutation in a patient with primary progressive multiple sclerosis
|
Bellinvia, Angelo |
|
|
44 |
C |
p. |
artikel |
5 |
An investigation of knee position sense, balance, and dual task performance in different phases of menstrual cycle in females with multiple sclerosis: a pilot study
|
ATEŞ, Yasemin |
|
|
44 |
C |
p. |
artikel |
6 |
An overview of lipidomic analysis in different human matrices of multiple sclerosis
|
Ferreira, Helena Beatriz |
|
|
44 |
C |
p. |
artikel |
7 |
Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis
|
Bates, Molly |
|
|
44 |
C |
p. |
artikel |
8 |
Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting
|
Block, Allison |
|
|
44 |
C |
p. |
artikel |
9 |
Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life
|
Hanna, Mariam |
|
|
44 |
C |
p. |
artikel |
10 |
Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
|
Conte, William L |
|
|
44 |
C |
p. |
artikel |
11 |
Atypical MOG antibody disease presenting with typical multiple sclerosis lesions
|
Dolbec, Katelyn |
|
|
44 |
C |
p. |
artikel |
12 |
Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics
|
Arenas Vargas, Laura Estefanía |
|
|
44 |
C |
p. |
artikel |
13 |
Biotinidase deficiency in differential diagnosis of neuromyelitis optica spectrum disorder
|
Bilge, Nuray |
|
|
44 |
C |
p. |
artikel |
14 |
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years ago
|
Lycke, Jan |
|
|
44 |
C |
p. |
artikel |
15 |
Cannabis extract for the treatment of painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report
|
Tisavipat, Nanthaya |
|
|
44 |
C |
p. |
artikel |
16 |
Cerebral hemodynamics in patients with multiple sclerosis
|
Lattanzi, Simona |
|
|
44 |
C |
p. |
artikel |
17 |
Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis
|
Dobson, Ruth |
|
|
44 |
C |
p. |
artikel |
18 |
Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders
|
Zhang, Juan |
|
|
44 |
C |
p. |
artikel |
19 |
Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort
|
Edgar Patricio, Correa-Díaz |
|
|
44 |
C |
p. |
artikel |
20 |
Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study
|
Lu, Hui |
|
|
44 |
C |
p. |
artikel |
21 |
Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) – a case report
|
Boucher, John J |
|
|
44 |
C |
p. |
artikel |
22 |
Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients
|
Mousavi, Seyyed Reza |
|
|
44 |
C |
p. |
artikel |
23 |
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study
|
Kolčava, Jan |
|
|
44 |
C |
p. |
artikel |
24 |
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
|
Aguirre, Clara |
|
|
44 |
C |
p. |
artikel |
25 |
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
|
Meca-Lallana, Virginia |
|
|
44 |
C |
p. |
artikel |
26 |
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
|
Buonomo, Antonio |
|
|
44 |
C |
p. |
artikel |
27 |
Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab
|
Gasparini, Sara |
|
|
44 |
C |
p. |
artikel |
28 |
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic
|
Abboud, Hesham |
|
|
44 |
C |
p. |
artikel |
29 |
Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey
|
Ricardo, Alonso |
|
|
44 |
C |
p. |
artikel |
30 |
Do you believe in Gad?
|
Maghzi, A.-H. |
|
|
44 |
C |
p. |
artikel |
31 |
Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis
|
Alizadeh-Fanalou, Shahin |
|
|
44 |
C |
p. |
artikel |
32 |
Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosis - A controlled pilot-trial
|
Van Geel, Fanny |
|
|
44 |
C |
p. |
artikel |
33 |
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis
|
Yan, Kevin |
|
|
44 |
C |
p. |
artikel |
34 |
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
|
Meca-Lallana, Virginia |
|
|
44 |
C |
p. |
artikel |
35 |
Estimating the risk of COVID-19 in multiple sclerosis patients in Buenos Aires, Argentina
|
Cristiano, E |
|
|
44 |
C |
p. |
artikel |
36 |
Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
|
Sahraian, Mohammad Ali |
|
|
44 |
C |
p. |
artikel |
37 |
Evolution of tongue somatosensory evoked potentials in people with multiple sclerosis
|
Krbot Skorić, Magdalena |
|
|
44 |
C |
p. |
artikel |
38 |
Familial clustering of neuromyelitis optica and multiple sclerosis: clues pointing towards shared risks?
|
Bonnan, Mickael |
|
|
44 |
C |
p. |
artikel |
39 |
FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire?
|
Budhram, Adrian |
|
|
44 |
C |
p. |
artikel |
40 |
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
|
Crescenzo, Francesco |
|
|
44 |
C |
p. |
artikel |
41 |
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors
|
Ziliotto, Nicole |
|
|
44 |
C |
p. |
artikel |
42 |
Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13
|
Olesen, M.N. |
|
|
44 |
C |
p. |
artikel |
43 |
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes
|
Martinelli-Boneschi, Filippo |
|
|
44 |
C |
p. |
artikel |
44 |
Incidence, prevalence and characteristics of MS in São Miguel, an island in the Atlantic
|
Lopes, Pedro |
|
|
44 |
C |
p. |
artikel |
45 |
Interferon Beta-1a Cardiomyopathy in a Patient with Multiple Sclerosis: Case Report
|
Cheraghmakani, H. |
|
|
44 |
C |
p. |
artikel |
46 |
Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD)
|
Li, Xindi |
|
|
44 |
C |
p. |
artikel |
47 |
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
|
Lucchini, Matteo |
|
|
44 |
C |
p. |
artikel |
48 |
Large hemispheric lesions in autoimmune encephalitis associated with anti-GAD 65 antibodies
|
Sianati, Bahareh |
|
|
44 |
C |
p. |
artikel |
49 |
Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources.
|
Viswanathan, S. |
|
|
44 |
C |
p. |
artikel |
50 |
Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument
|
Ahmad, Hasnat |
|
|
44 |
C |
p. |
artikel |
51 |
Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis
|
Yanwu, Yang |
|
|
44 |
C |
p. |
artikel |
52 |
Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients
|
Fahmi, Rasha M. |
|
|
44 |
C |
p. |
artikel |
53 |
Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder.
|
Creed, Marina A. |
|
|
44 |
C |
p. |
artikel |
54 |
Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab
|
Guevara, Carlos |
|
|
44 |
C |
p. |
artikel |
55 |
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone
|
Foo, E.C. |
|
|
44 |
C |
p. |
artikel |
56 |
Mortality trend for multiple sclerosis in Italy during the period 1980–2015
|
Bezzini, Daiana |
|
|
44 |
C |
p. |
artikel |
57 |
Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan
|
Lin, Wei-Sheng |
|
|
44 |
C |
p. |
artikel |
58 |
Multiple sclerosis coverage in the written media of a low prevalence country
|
Cárdenas-Robledo, Simón |
|
|
44 |
C |
p. |
artikel |
59 |
Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey
|
Inan, Berin |
|
|
44 |
C |
p. |
artikel |
60 |
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
|
Thornton, Jeanine Rempe |
|
|
44 |
C |
p. |
artikel |
61 |
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm
|
Domurath, Burkhard |
|
|
44 |
C |
p. |
artikel |
62 |
Normative values of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in an Arab population: Corrected for age, sex and education
|
Alboudi, Ayman |
|
|
44 |
C |
p. |
artikel |
63 |
Optic neuropathy: A 15-year retrospective observational study
|
Alves, José Miguel |
|
|
44 |
C |
p. |
artikel |
64 |
Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees
|
Hua, Le H. |
|
|
44 |
C |
p. |
artikel |
65 |
Patients' perspective and usability of innovation technology in a new rehabilitation pathway: An exploratory study in patients with multiple sclerosis
|
Manuli, Alfredo |
|
|
44 |
C |
p. |
artikel |
66 |
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
|
Matías-Guiu, Jorge |
|
|
44 |
C |
p. |
artikel |
67 |
Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder
|
Ashtari, Fereshteh |
|
|
44 |
C |
p. |
artikel |
68 |
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules
|
Fuentes-Rumí, Luna |
|
|
44 |
C |
p. |
artikel |
69 |
RETRACTED: Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis
|
Kwapong, William Robert |
|
|
44 |
C |
p. |
artikel |
70 |
Retraction notice to Retinal microvasculature alterations in neuromyelitis optica spectrum disorders before optic neuritis [Multiple sclerosis and related disorders 44 (2020) 102277]
|
Kwapong, William Robert |
|
|
44 |
C |
p. |
artikel |
71 |
“Rocking the boat” with a new drug for neuromyelitis optica spectrum disorder
|
Levy, Michael |
|
|
44 |
C |
p. |
artikel |
72 |
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis
|
Lotan, Itay |
|
|
44 |
C |
p. |
artikel |
73 |
Serial neuropsychological testing in MOG antibody-associated disease to improve understanding of outcomes
|
Kornbluh, AB |
|
|
44 |
C |
p. |
artikel |
74 |
Sex hormones secondary players in Susac's syndrome
|
Alungulese, Anca Loredana |
|
|
44 |
C |
p. |
artikel |
75 |
Spinal adhesive arachnoiditis mimicking sarcoid myelitis with nodular dural enhancement: A case report
|
Clark, Grace |
|
|
44 |
C |
p. |
artikel |
76 |
Subjective visual vertical and visual dependency in patients with multiple sclerosis
|
Ulozienė, I. |
|
|
44 |
C |
p. |
artikel |
77 |
Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis
|
Joly, H. |
|
|
44 |
C |
p. |
artikel |
78 |
The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis
|
Russell, R.D. |
|
|
44 |
C |
p. |
artikel |
79 |
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs
|
Ahmad, Hasnat |
|
|
44 |
C |
p. |
artikel |
80 |
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
|
Baker, David |
|
|
44 |
C |
p. |
artikel |
81 |
The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study
|
Barć, Krzysztof |
|
|
44 |
C |
p. |
artikel |
82 |
The transitional phase of multiple sclerosis: Characterization and conceptual framework
|
Kleiter, Ingo |
|
|
44 |
C |
p. |
artikel |
83 |
The unresolved role of the neurologist in providing dietary advice to people with multiple sclerosis
|
Russell, R.D. |
|
|
44 |
C |
p. |
artikel |
84 |
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
|
Whittam, Daniel H |
|
|
44 |
C |
p. |
artikel |
85 |
Trends and characteristics of infection-related hospital admissions in multiple sclerosis patients in Southwest Finland in 2009–2018
|
Pirttisalo, Anna-Leena |
|
|
44 |
C |
p. |
artikel |
86 |
Use of natural medicine and dietary supplements concomitant with conventional medicine among people with Multiple Sclerosis
|
Bergien, S.O. |
|
|
44 |
C |
p. |
artikel |
87 |
Vestibulo-ocular reflex involvement in childhood-onset multiple sclerosis
|
Ertugrul, Gorkem |
|
|
44 |
C |
p. |
artikel |
88 |
Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases
|
Nali, Luiz H. |
|
|
44 |
C |
p. |
artikel |